Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden
· Delayed Price · Currency is SEK 0.103
-0.021 (-17.04%)
Mar 9, 2026, 4:56 PM CET
Novakand Pharma AB Market Cap
Novakand Pharma AB has a market cap or net worth of 15.08 million as of March 9, 2026. Its market cap has decreased by -87.76% in one year.
Market Cap
15.08M
Enterprise Value
-997.43K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since February 28, 2011, Novakand Pharma AB's market cap has decreased from 90.09M to 15.08M, a decrease of -83.27%. That is a compound annual growth rate of -11.22%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fluicell AB | 14.84M |
| NanoEcho AB | 12.98M |
| Aptahem AB | 18.41M |
| Stayble Therapeutics AB | 11.17M |
| ExpreS2ion Biotech Holding AB | 20.72M |
| Guard Therapeutics International AB | 32.27M |
| Modus Therapeutics Holding AB | 35.15M |
| Nanologica AB | 35.35M |